Search - Université de Rennes Access content directly

Filter your results

29 Results
Structure: Internal structure identifier : 116455
Image document

Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance

Charly Jehanno , Tamara Fernández-Calero , Denis Habauzit , Stéphane Avner , Frédéric Percevault et al.
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms , 2020, 1863 (5), pp.194507. ⟨10.1016/j.bbagrm.2020.194507⟩
Journal articles hal-02565572v1
Image document

Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition

Jacques Galipeau , Mauro Krampera , Katarina Leblanc , Jan A Nolta , Donald G Phinney et al.
Cytotherapy, 2021, 23 (5), pp.368-372. ⟨10.1016/j.jcyt.2020.11.007⟩
Journal articles hal-03229071v1
Image document

Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions

Charly Jehanno , Frédéric Percevault , Noureddine Boujrad , Pascale Le Goff , Coralie Fontaine et al.
Molecular and Cellular Endocrinology, 2021, 530, pp.111282. ⟨10.1016/j.mce.2021.111282⟩
Journal articles hal-03221142v1

Vitamin D as an early predictor of multiple sclerosis activity and progression.

Alberto Ascherio , Kassandra L. Munger , Rick White , Karl Köchert , Kelly Claire Simon et al.
JAMA neurology, 2014, pp.306-14
Journal articles inserm-01103094v1
Image document

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.

Perrine Janiaud , Cathrine Axfors , Janneke Van’t Hooft , Ramon Saccilotto , Arnav Agarwal et al.
F1000Research, 2020, 9, pp.1193. ⟨10.12688/f1000research.26707.2⟩
Journal articles hal-03000824v1

Cortical lesion detection using FLAWS in multiple sclerosis

J. Muller , R. Rahmanzadeh , C. Tsagkas , M. Barakovic , P. -J. Lu et al.
Multiple Sclerosis Journal, 2021, 27 (2_SUPPL), pp.433-434
Journal articles hal-03463740v1

Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012)

Gilles Edan , Mark Freedman , Xavier Montalban , David Miller , Hans Hartung et al.
Neurology, 2015, 84 (14 Supplement), pp.P7.012
Journal articles hal-01259391v1
Image document

Consensus-based guidance for conducting and reporting multi-analyst studies

Balazs Aczel , Barnabas Szaszi , Gustav Nilsonne , Olmo van den Akker , Casper Albers et al.
eLife, 2021, 10, pp.e72185. ⟨10.7554/eLife.72185⟩
Journal articles inserm-03431812v1
Image document

Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells.

Luc Sensebé , Karin Tarte , Jacques Galipeau , Mauro Krampera , Ivan Martin et al.
Cell Stem Cell, 2012, 10 (1), 9-10; author reply 10-1. ⟨10.1016/j.stem.2011.12.005⟩
Journal articles inserm-00817456v1

Predicting conversion to clinically definite multiple sclerosis using machine learning on the basis of cerebral grey matter segmentations

K. Bendfeldt , B. Taschler , L. Gaetano , P. Madoerin , P. Kuster et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.498--499
Journal articles hal-01259385v1

Vitamin D and the development and evolution of permanent black holes among patients with clinically isolated syndrome

K. C. Fitzgerald , K. Munger , M. S. Freedman , H. -P. Hartung , X. Montalban et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.399--400
Journal articles hal-01259388v1

Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11)

F. Foley , I. -K. Penner , Gilles Edan , M. S. Freedman , X. Montalban et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.249--251
Journal articles hal-01259395v1

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

J Kuhle , M Hardmeier , G Disanto , K Gugleta , M Ecsedi et al.
Multiple Sclerosis Journal, 2015, 22 (4), pp.533-43. ⟨10.1177/1352458515594440⟩
Journal articles hal-01201949v1

7TH INTERIM ANALYSIS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) AND JOINT HEALTH IN PATIENTS WITH HEMOPHILIA A: AHEAD INTERNATIONAL

K. Khair , J. Oldenburg , D. A. Tsakiris , R. Klamroth , B. Guillet et al.
Haemophilia, 2021, 27 (S2), pp.36-36. ⟨10.1111/hae.14236⟩
Journal articles hal-03162284v1

REAL WORLD BLEEDING RATES OVER 7 YEARS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN PATIENTS WITH HEMOPHILIA A AND TARGET JOINTS: AHEAD INTERNATIONAL

M. C. Ozelo , D. A. Tsakiris , R. Klamroth , B. Guillet , K. Khair et al.
Haemophilia, 2021, 27 (S2), pp.112-113
Journal articles hal-03162296v1
Image document

The basal level of gene expression associated with chromatin loosening shapes Waddington landscapes and controls cell differentiation

Gilles Flouriot , Charly Jehanno , Yann Le Page , Pascale Le Goff , Benjamin Boutin et al.
Journal of Molecular Biology, 2020, 432 (7), pp.2253-2270. ⟨10.1016/j.jmb.2020.02.016⟩
Journal articles hal-02109253v1

Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis

Jannis Müller , Francesco La Rosa , Jeremy Beaumont , Charidimos Tsagkas , Reza Rahmanzadeh et al.
Investigative Radiology, 2022, Publish Ahead of Print, ⟨10.1097/RLI.0000000000000877⟩
Journal articles hal-03689749v1
Image document

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates

Stéphanie Leroux , Valérie Biran , John van den Anker , Verena Gotta , Wei Zhao et al.
Frontiers in Pharmacology, 2021, 12, pp.386. ⟨10.3389/fphar.2021.634686⟩
Journal articles hal-03216851v1

AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING

J. Oldenburg , M. C. Ozelo , R. Klamroth , B. Guillet , A. Huth-Kuehne et al.
Haemophilia, 2020, 26 (S2), pp.87-87. ⟨10.1111/hae.13911⟩
Journal articles hal-02501205v1
Image document

The challenge of mapping the human connectome based on diffusion tractography

Klaus H Maier-Hein , Peter F. Neher , Christophe Houde , Marc-Alexandre Côté , Eleftherios Garyfallidis et al.
Nature Communications, 2017, 8 (1), ⟨10.1038/s41467-017-01285-x⟩
Journal articles hal-01631578v1

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

Angelo Ghezzi , Maria Pia Amato , Gilles Edan , Hans-Peter Hartung , Eva Kubala Havrdová et al.
Multiple Sclerosis Journal, 2021, 27 (3), pp.479-482. ⟨10.1177/1352458520930620⟩
Journal articles hal-02887839v1

MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11)

F. Barkhof , M. P. Wattjes , Gilles Edan , M. S. Freedman , X. Montalban et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.238--239
Journal articles hal-01259398v1

Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)

Mark S. Freedman , Ludwig Kappos , Gilles Edan , Xavier Montalban , Hans-Peter Hartung et al.
Multiple Sclerosis Journal, 2016, 22, pp.19--20
Journal articles hal-01300794v1

Survey of diagnostic and treatment practices for multiple sclerosis in Europe

Óscar Fernández , M. Delvecchio , Gilles Edan , Sten Fredrikson , Gavin Giovannoni et al.
European Journal of Neurology, 2017, 24 (3), pp.516 - 522. ⟨10.1111/ene.13236⟩
Journal articles inserm-01576518v1

The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020

Viktoria Gloy , Andreas M Schmitt , Pascal Düblin , Julian Hirt , Cathrin Axfors et al.
International Journal of Cancer, 2023, ⟨10.1002/ijc.34473⟩
Journal articles hal-04040824v1
Image document

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

Aviv Ladanie , Andreas M Schmitt , Benjamin Speich , Florian Naudet , Arnav Agarwal et al.
JAMA Network Open, 2020, 3 (11), pp.e2024406. ⟨10.1001/jamanetworkopen.2020.24406⟩
Journal articles hal-03037506v1

Sodium intake and multiple sclerosis activity and progression in BENEFIT

Kathryn C. Fitzgerald , Kassandra L. Munger , Hans-Peter Hartung , Mark S. Freedman , Xavier Montalbán et al.
Annals of Neurology, 2017, 82 (1), pp.20 - 29. ⟨10.1002/ana.24965⟩
Journal articles inserm-01576520v1

Optical coherence tomography and ophthalmological findings in patients with CIS treated with interferon beta-1b: 11-year follow-up in BENEFIT (BENEFIT 11)

S. Lukas , J. V. M. Hanson , Gilles Edan , M. S. Freedman , X. Montalban et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.240--241
Journal articles hal-01259384v1
Image document

Role of Survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study

Romain Mathieu , Ilaria Lucca , Mihai Dorin Vartolomei , Aurélie Mbeutcha , Tobias Klatte et al.
BJU International, 2017, 119 (2), pp.234-238. ⟨10.1111/bju.13472⟩
Journal articles hal-01290421v1